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 Eveningness, a preference for later sleep and rise times, has been associated with a 





evidence links eveningness to Major Depressive Disorder (MDD). However, to date, 
evidence quantifying this association is limited. The current meta-analysis included 43 effect 
sizes from a total 27,996 participants. Using a random-effects model it was demonstrated that 
eveningess is associated with a small effect size (Fisher’s Z = -2.4, 95% CI [-0.27. -0.21], p < 
.001). Substantial heterogeneity between studies was observed, with meta-regression analyses 
demonstrating a significant effect of mean age on the association between diurnal preference 
and depression. There was also evidence of potential publication bias as assessed by visual 
inspection of funnel plots and Egger’s test. The association between diurnal preference and 
depression is small in magnitude and heterogenous. A better understanding of the 
mechanistic underpinnings linking diurnal preference to depression and suitably powered 













 Circadian rhythms are endogenous processes that follow a near 24-hour cycle.  These 
rhythms are self-autonomous, and in humans are controlled by a central oscillator (or master 
clock) located in the suprachiasmatic nuclei (SCN) of the hypothalamus1.  Individuals 
maintained under constant conditions isolated from external timing cues can maintain an 
endogenous period close to 24 hours. However, because these cycles oscillate with periods 
that differ slightly from 24 hours there is a loss of synchrony with the earth’s day-night cycle. 
To account for this, the central oscillator is adaptable and can be entrained to respond to 
external time-givers, or zeitgebers (e.g., light). The molecular mechanisms underlying the 
generation of circadian oscillations relies on multiple proteins generated by clock-related 
genes that interact to inhibit and activate gene expression in an inhibitory loop that oscillates 
to produce the near-24-hour cycle. 
Disruption of circadian rhythms are widely reported in depression. Patients may 
display a regular daily pattern of symptoms with increased symptom severity often reported 
in the morning2. In MDD there are dampened and phase-shifted rhythms of activity, 
temperature and hormones (with the exception of cortisol which is increased rather than 
reduced)3 which are correlated with depressive symptom severity4.  Disrupting circadian 
rhythms through shift-work, long-distance travel (jet-lag) or misalignment between internal 
(biological)  and social (external) time (referred to as social jet-lag) has been observed to 
increase depressive symptoms5–7. Poor entrainment of the SCN to light (as may occur in 
Major Depressive Disorder with Seasonal  Pattern) and the subsequent disruptions of daily 
rhythms of hormones and neurotransmitters has been reported as an additional factor to 
develop depression8. In addition, treatments that target circadian rhythms (e.g. agomelatine, 





Diurnal preference, or morningness/eveningness, reflects an individual’s preferred 
timings for sleep and activity and is an individual trait that arises through a combination of 
endogenous factors and external, environmental stimuli10.  Evening-types (colloquially 
referred to as “night owls”) prefer to go to bed late, rise late and plan work and other 
activities (e.g., meetings, gym visits) for later in the day. By contrast, morning-types (“larks”) 
prefer to retire early, rise early and plan activities for earlier in the day.  
 Diurnal preference can be reliably estimated using subjective assessment, which has 
particular utility for large scale studies. A number of instruments have been developed to 
measure eveningess and among the most widely used are the Morningness-Eveningness 
Questionnaire (MEQ)11, the reduced version of the MEQ12 and the Composite Scale of 
Morningness (CSM)13. All three measures have been shown to have moderate to good 
reliability and construct validity14 and the MEQ has also been demonstrated to be a strong 
predictor of dim melatonin onset - which is considered the most reliable measure of circadian 
rhythm in humans15. 
Twin studies indicate heritability estimates between 46% and 57% for diurnal 
preference16 and diurnal preference is considered a relatively stable trait in adulthood17. A 
better understanding of individual differences in sleep-wake behaviour and how these may 
relate to disease is becoming increasingly important as a large body of work now suggests 
that eveningness is associated with a number of negative physical18 and mental health 
outcomes19,20 particularly depression21,22.  Current evidence suggests that eveningess is 
associated with greater depressive symptomatology7,22,23. Eveningness is also associated with 
having a current diagnosis of depression, treatment for depression or antidepressant use 
22,24,25, non-remission26 and suicidal thoughts27. 
Despite the prevalence and debilitating nature of depression and the overwhelming 





synthesis of these data has been largely restricted to systematic reviews (e.g. 19,20,28,29). To 
date,  only one study has quantified this relationship in the form of a meta-analysis30. The aim 
of the current study was to extend this previous meta-analysis30 (which was limited to data 
published up to February 2016) to include recent literature published up to 31st December 
2020.  Based on previous work it is hypothesised that eveningess will be associated with 
greater depressive symptomatology.  
 
Methods 
The protocol for this meta-analysis was prospectively registered with PROSPERO 
(CRD4202122977).  
Literature search 
PubMed and Web of Science were searched for articles published between 1st January 
2000 and 31st December 2020 using the search terms ("chronotype" OR "diurnal preference" 
OR "circadian preference" OR "morningness" OR "eveningness" OR "social jetlag" ) AND 
("depression" OR "MDD" OR "Unipolar"). The titles and abstracts of articles returned using 
this search were initially screened before the full text was examined in greater detail. 
To be included in the meta-analysis articles were required to meet the following 
criteria: 1) Diurnal preference quantified using either the Morning-Evening Questionnaire11 
the Reduced Morningness-Eveningness Questionnaire12 or the Composite Scale of 
Morningness13; 2) Depressive symptomatology measured using either the Beck Depression 
Inventory (BDI)31, the Hospital Anxiety and Depression Scale (HADS)32, the Hamilton 
Rating Scale for Depression (HRSD)33, the Depression, Anxiety, Stress Scales (DASS)34, the 
Quick Inventory of Depressive Symptomatology–Self-report (QUIDS-SR)35, the Centre for 





Montgomery-Asberg Depression Rating Scale–Self  (MADRS-S)38, the Patient Health 
Questionnaire 9 (PHQ-9)39, the Patient Health Questionnaire 4 (PHQ-4)40, the Brief 
Symptom Rating Scale (BSRS)41, the Geriatric Depression Scale (GDS)42 and the Depressed 
Mood Scale  (DMS)43; 3) Sufficient statistical information to estimate an effect size 
(correlation coefficient, mean and standard deviation or standard error, odds ratio); 4) Written 
in English; 5) Participants aged 18 or over; 6) For clinical samples, patients diagnosed with 
MDD;  and 5) Published in a peer-reviewed journal. Exclusion criteria were: 1) Studies that 
included depressive disorders other than MDD (e.g., Seasonal Affective Disorder); and 2) 
Incomplete or modified versions of the MEQ/rMEQ/CSM (e.g. diurnal preference determined 
using a single question). Data selection is summarised in Figure S1, supplemental data. 
Study quality was evaluated using the McMaster critical review tool for quantitative 
studies44. Data extracted from the included studies was: 1) Authorship; 2) Year of 
publication; 3) Sample size; 4) Mean age; 5) Age range; 6) Measure of diurnal preference 
(e.g., MEQ); 7) Depression measure (e.g. BDI); 8) Gender breakdown (e.g. percentage of 
female participants); and 9) Clinical or non-clinical samples. 
Statistical analyses 
 All statistical analyses were performed using R version 3.6.145 including the 
following packages: esc; effectsize; meta; metafor; dmetar: DiagrammeR; DiagrammeRsvg; 
and ggplot2.  Individual effect sizes were obtained from each study.  As most studies (52%) 
reported correlation coefficients, Fisher’s Z transformed correlation coefficient was used as 
the summary effect size.  Odds ratios and standardised mean differences were transformed to 
Fisher’s Z scores for inclusion in the analysis. The corresponding pooled effect size and its 
95% confidence intervals (CI) were calculated from a random-effects model with a Sidik-
Jonkman estimator for τ2 with Hartung-Knapp adjustment.  This method was adopted as a 





0.3  was considered small, 0.3 – 0.5 medium and 0.5 – 1 considered a large effect 48. Study 
heterogeneity was assessed with Q statistics and the I2 index. Outlier analysis (studies were 
considered outliers if the 95% CI was outside the pooled effect size 95% CI) were also 
performed and the random-effects model refitted after excluding any such study.  To assess 
the potential impact of publication bias, funnel plots were visually inspected, and an Egger’s 
test conducted to quantify asymmetry with a p value of < .05 considered evidence of 
asymmetry that may reflect publication bias. Based on the outcome of the Egger’s test, a trim 
and fill procedure was conducted to impute potential missing studies into the funnel plot to 
achieve symmetry. Categorial moderators (clinical vs. non-clinical, diurnal preference 
measure, clinical measure and published in 2020 vs any other year (this latter analysis was 
included as studies published in 2020 overlap with the COVID-19 outbreak and may 
therefore include data collected during the pandemic) were investigated uses subgroup 
analyses. Continuous variables (age, year of publication, sample size and percentage of 
female participants) were explored using meta-regression. 
Results 
 The initial literature search returned 865 articles (PubMed = 318, Web of Science 
=546, see supplemental S1 for a graphical overview). Following article screening, a total of 
51 studies were entered into the initial random effects model.  Outlier analyses identified a 
total of ten studies 49–58 and these were subsequently excluded from the analysis (See 
supplemental S2 for details of these studies including the 95% CI for each excluded effect 
size).  Heterogeneity was reduced after excluding these studies (prior to exclusion I2 = 77.9%, 
Q(52) = 235.11, p < .001, after exclusion I2 = 60.2%, Q(42) = 105.5, p < .001) but remained 
substantial and significant.  The final sample included 43 effect sizes from a total 27,996 
participants with a mean age of 32 years. The predominant measure of eveningness was the 





depressive symptomatology (respectively, 26% and 19%) and non-clinical samples made up 
86% of effect sizes. Details of the included studies are shown in Table 1. 
 The effect size estimated from the random-effects model was Fisher’s Z = -0.24, 95% 
CI [-0.27. -0.21], p < .001, demonstrating a small, but significant, association between 
eveningness and depression symptomatology (Figure 1).  Visual inspection of the funnel plot 
(Figure 2) and the result of the Egger’s test of the intercept (-1.135, 95% CI[-1.86, -0.41], p = 
.004) suggest publication bias should be taken into consideration when interpreting the results 
and the trim and fill adjusted estimate was -0.21, 95% CI [-0.2438; -0.1715], p < .0001 with 
twelve adjusted studies. 
 The substantial heterogeneity between studies suggests a potential impact of 
moderator variables on the reported association between eveningness and depressive 
symptomatology. To explore this a series of sub-group meta-analyses were conducted based 
on four potential confounders : Sample composition (clinical vs. non-clinical); Publication 
year (2020 vs. other year); Eveningness measure ( MEQ vs. CSM vs. rMEQ) and Depression 
measure (BDI vs. CES-D vs. other). None of the included categorical moderators 
significantly explained heterogeneity in effect size.  A summary of subgroup analyses is 
presented in Table 2. Meta-regression demonstrated that age was negatively associated with 
depression symptomatology (β = -0.003, p = 0.03, 95% CI [-0.005, - 0.0003], R2 = 10.63, 
Figure 3). Neither sample size (β = 0.00, p = 0.12, 95% CI [-0.00, 0.00], R2 = 4.44), year of 
publication (β = -0.02, p = 0.56, 95% CI [-0.09, 0.05], R2 = 0) or percentage of female 
participants (β = 0.00, p = 0.95, 95% CI [-0.002, 0.002], R2 = 0) were related to the observed 








Author Chronotype       Age       N    Females (%) Sample Depression Measure 
Akram et al.,60 MEQ 24 453 75 Non-clinical HADS - depression subscale 
Asarnow et al.,61 CSM 43 139 66 Clinical HRSD  
Aydin et al.,62 MEQ 22 209 49 Non-clinical DASS-21 depression subscale 
Bakotic et al.,63 CSM 21 1052 62 Non-clinical HADS - depression subscale 
Berdynaj et al.,64 MEQ 21 86 78 Non-clinical DMS  
Chan et al.,26 MEQ 51 253 84 Clinical BDI  
Coleman & Cain65 rMEQ 46 424 73 Clinical HRSD  
Furusawa et al.,66 MEQ 41 362 0 Non-clinical SDS  
Gaspar-Barba et al.,27 MEQ 32 82 37 Clinical BDI  
Haraszti et al.,67 MEQ 38 44 100 Non-clinical PHQ-9  
Hidalgo et al.,23 MEQ 31 142 61 Non-clinical QUIDS-SR  
Hirata et al.,68 MEQ 22 33 52 Non-clinical SDS  
Horne et al., 53 rMEQ 24 167 77 Non-clinical CES-D  
Hou et al., 69 MEQ 37 884 63 Non-clinical CES-D  
Hsu et al., 70 MEQ 20 790 53 Non-clinical MADRS  
Inomata et al.,71 MEQ 21 27 48 Non-clinical CES-D  
Jankowski & Dmitrzak-
Weglarz,72 CSM 32 338 51 Non-clinical HADS - depression subscale 
Jankowski,73 CSM 22 974 70 Non-clinical PHQ-4 - depression subscale 
Jeon et al.,74 MEQ 32 700 91 Non-clinical CES-D  
Kang et al.,75 rMEQ 19 940 63 Non-clinical DASS-21 depression subscale 
Khan et al.,76 MEQ 40 59 54 Non-clinical BSRS  
Lau et al.,77 CSM 21 230 66 Non-clinical CES-D  
Lester,78 MEQ 22 194 72 Non-clinical CES-D  
Liberman et al.,79 MEQ 19 242 64 Non-clinical CES-D  
Lin et al.,80 rMEQ 27 1791 70 Non-clinical CES-D  





Müller et al.,82 MEQ 42 64 61 Clinical BDI  
Ong et al.,83 CSM 49 156 NR Non-clinical BDI-short form 
Park et al.,84 CSM 19 5632 51 Non-clinical DASS-21 depression subscale 
Park85 CSM 37 29 72 Clinical BDI  
Przepiorka et al.,86 CSM 20 398 71 Non-clinical BDI  
Randler et al.,87 CSM 22 277 100 Non-clinical HADS - depression subscale 
Selvi et al.,59* MEQ 31 80 55 Non-clinical BDI-II  
Smagula et al.,88 CSM 70 54 70 Non-clinical PHQ-9  
Sun et al.,89 rMEQ 48 629 NR Non-clinical CES-D  
Togo et al.,90 MEQ 41 2669 97 Non-clinical CES-D  
Toomey et al.,91 MEQ 55 1231 NR Non-clinical BDI  
Türkoglu & Selvi92 MEQ 42 70 83 Non-clinical CES-D  
Üzer & Yücens58* MEQ 65 70 50 Non-clinical PHQ-9  
Üzer & Yücens93 MEQ 22 339 54 Non-clinical BDI  
Watts & Norbury94 rMEQ 26 240 79 Non-clinical BDI  
Zhang et al.,95 MEQ 19 616 65 Non-clinical PHQ-9  
Zhou et al.,96 MEQ 19 4531 30 Non-clinical HADS - depression subscale 
 
 
Table 1. Study characteristics. For abbreviations please see main text. * Two effect sizes were initially estimated for each of these studies two of 









Figure 1. Forest plot of standardised effect sizes from each study. The overall effect is 









Figure 2. Contour funnel plot indicating potential risk of publication bias. Open dots 





















Z 95% CI Q  p value 
        
Sample composition Clinical 7 -0.27 -0.37 -0.17   
 Non-clinical 36 -0.23 -0.26 -0.20 0.52 0.47 
        
Publication year 2020 12 -0.24 -0.31 -0.16   
 Other year& 31 -0.24 -0.27 -0.21 0.00 0.94 
        
Eveningness measure CSM 11 -0.24 -0.31 -0.17   
 MEQ 26 -0.24 -0.28 -0.20   
 rMEQ 6 -0.24 -0.30 -0.17 0.00 0.99 
        
Depression measure BDI 12 -0.25 -0.32 -0.18   
 CES-D 10 -0.23 -0.28 -0.18   
 Other&& 21 -0.24 -0.28 -0.20 0.13 0.94 
        
        
 
Table 2. Subgroup analysis. Other year&  = publication year other than 2020; Other&&  = any depression measure other than BDI or CES-D (see 









Figure 3.  Regression of effect size (Fisher’s Z) on age. Line of best fit plus confidence 










 The current findings demonstrate a small but significant association between diurnal 
preference and depressive symptomatology. All of the reported studies indicated a positive 
association between eveningness and depression, ranging between -0.52 and -0.03.  The 
summary effect size for the random effects model was -.24 which is largely consistent with 
an earlier meta-analysis 30 that reported an effect size of -0.2 and together these data suggest a 
small but reliable association between eveningness and depression. Contrary to the findings 
of Au and Reece, in the current analysis evidence of a potential publication bias (i.e. 
statistically significant or favourable results being more likely to be published than studies 
with non-significant or unfavourable results) was observed.  The adjusted effect size (Fishers 
Z = -0.21), however, remained significant. Subgroup analyses demonstrated no moderating 
effect of sample characteristics, eveningness or depression measure, or studies published in 
2020 vs. any other year. Meta-regression showed a significant effect of age on the association 
between eveningess and depression symptomatology, but no evidence for a moderating effect 
of sample size, gender ratio, or year of publication. 
 A long-standing question in the literature is one of directionality; does eveningess 
cause depression or is eveningness a consequence of the disorder? The cross-sectional studies 
quantified here cannot speak directly to this question.  However, the current results 
demonstrated no significant difference between clinical and non-clinical samples, a finding 





depression rather than a consequence of the depressed state.  The vulnerability-stress 
hypothesis of depression97,98 proposes that depression emerges through an interaction 
between psychological vulnerability factors (e.g., negative biases/preferential processing of 
negative material) and an environmental stressor (e.g., bereavement, financial insecurity). 
Importantly, previous work suggests that eveningness is associated with aspects of negative 
thinking (i.e. psychological vulnerability factors) in never-depressed individuals. For 
example, eveningness has been associated with greater recall for negative personality trait 
words, greater recognition of sad facial expressions64,99 and maladaptive emotion regulation 
strategies94,100. Similarly, high neuroticism (i.e. individuals who are emotionally reactive and 
tend to experience more negative emotions and depression) has also been associated with 
eveningness101. Converging evidence, therefore, suggests that in healthy, never-depressed 
individuals, eveningness  is associated with depressogenic personality types, negative biases 
in emotional processing and impaired emotion regulation which, if combined with adversity, 
may lead to depression. These findings also suggest modifiable markers that could be 
therapeutically targeted to prevent the onset of depression in evening type individuals. 
 Of the moderators tested here only age was significantly associated with effect size. 
This contrasts with the findings of Au and Reece (2017) who did not observe a similar 
relationship. The mean age range in the current study was 19-70, which is broader than 
included by Au and Reece (19 – 55, MDD sample only) which may account for the 
discrepancy. Although it should be noted that for the majority of studies included here 
(~50%)  the mean age was less than 30 years of age.  Of note, Kim et al. (2020) recently 
reported no difference in prevalence rates for depression in late chronotypes vs. neither types 
in a population of Korean adults stratified by age (19-40, 41-59 and 60-80 years). However, 
although the total sample size was large (N = 6382) the number of participants in the older 





interoperability102.  Counter to this, eveningness has been associated with increased odds for 
reporting depression in a large sample of older adults (age range 40 – 70 years) taken from 
the UK Biobank103. Similarly, here increasing age was associated with increased depressive 
symptomatology but the factors underpinning this effect remain to be elucidated. Older 
individuals that remain more evening-type may gradually lose friendship networks and group 
allegiances as peers gravitate to a social schedule in synchrony with their changing circadian 
typology, potentially leaving evening-prone individuals more isolated and potentially more 
prone to depression.  This notion, however, is purely speculative and requires further 
investigation with suitably powered, prospective studies to determine the potential impact of 
age on the association between eveningness and depression. 
 There are several limitations associated with this work which should be considered 
when interpreting the results. A general limitation of meta-analyses is that by creating a 
summary of outcomes, important between-study differences are ignored. To formally address 
this here study inclusion was restricted to adults, for clinical samples mood disorders other 
than MDD were excluded and only studies that used validated instruments to measure 
depressive symptomatology and diurnal preference were included. In addition, moderator 
analysis and meta-regression were employed to explore study heterogeneity. More 
specifically, the current analysis was unable to account for important factors that may impact 
the results. Sleep duration and/or sleep quality, for example, were not taking into 
consideration (zero-order correlations or unadjusted odds-ratios/mean differences were 
reported).  Similarly, social jet-lag, the difference between internal rhythm and external 
demands (e.g. work or university), which may be more pronounced in evening-types and is 
associated with increased likelihood of reporting depressive symptoms104,105 was not included 
in this meta-analysis.  The current report, therefore, cannot directly assess the potential 





Further, the terms chronotype and diurnal preference are frequently used interchangeably in 
the literature but reflect different aspects of the same phenomenon.  Here, the focus was 
diurnal preference and the questionnaires included limited to the MEQ, rMEQ and CSM 
which determine morningness/eveningness  preferences based on self-reported preferences 
for times of activity and rest. These measures, therefore, reflect a personality trait. By 
contrast, instruments such as the Munich Chronotype Questionnaire (MCTQ) 106 measure 
behaviour (mid-point of sleep on free days) which can be viewed as an indicator of state107. 
The focus of the current report was unipolar depression, but increasing evidence links 
eveningness with other affective disorders such as bipolar disorder108  and Major Depressive 
Disorder with Seasonal  Pattern109 and anxiety110.  Future meta-analyses that review and 
synthesise the recent literature related to these disorders is warranted. Finally, it should also 
be noted that all phases of this review and analyses were conducted solely by the author. 
 In summary, the current meta-analysis demonstrated that eveningness is associated 
with depressive symptoms.  These data are largely consistent with a previous meta-analysis30 
and the extant literature. The underlying causes that lead to depression are likely 
multifactorial and progress in understanding the links between diurnal preference and 
depression is predicated on a better understanding of the mechanistic underpinnings and 
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